Insulet (PODD) Tops Q4 EPS by 3c
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $142.28 -3.53%
EPS Growth %: +28.2%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +28.2%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $369.7 million versus the consensus estimate of $332.18 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- GameStop beats second quarter estimates on collectibles
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
